aloxistatin has been researched along with Malaria, Falciparum in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cook, JL; Czesny, B; Goshu, S; Williamson, KC | 1 |
| Batinovic, S; Charman, S; Chiu, F; Crespo, MP; Dogovski, C; Hanssen, E; Klonis, N; Stafford, C; Teguh, S; Tilley, L; Xie, SC; Yang, T | 1 |
2 other study(ies) available for aloxistatin and Malaria, Falciparum
| Article | Year |
|---|---|
The proteasome inhibitor epoxomicin has potent Plasmodium falciparum gametocytocidal activity.
Topics: Animals; Cell Line; Cysteine Proteinase Inhibitors; Gametogenesis; Humans; Malaria, Falciparum; Mice; NIH 3T3 Cells; Oligopeptides; Oocysts; Plasmodium falciparum; Proteasome Endopeptidase Complex | 2009 |
Haemoglobin degradation underpins the sensitivity of early ring stage Plasmodium falciparum to artemisinins.
Topics: Antimalarials; Artemisinins; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Drug Evaluation, Preclinical; Drug Resistance; Drug Synergism; Hemoglobins; Humans; Lethal Dose 50; Leucine; Malaria, Falciparum; Plasmodium falciparum; Proteolysis; Protozoan Proteins | 2016 |